1The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med, 1995, 333(5): 1580-1587. 被引量：1
2Hacke W, Kaste M, Fieschi C, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study(ECASS ).JAMA, 1995, 274 (5): 1017-1025. 被引量：1
3Wardlaw JM, Warlow CP. Thrombolysis in acute ischemic stroke:does it work? Stroke, 1992, 23(12): 1826-1839 被引量：1
4Mori E, Yoneda Y, Tabuchi M, et al. Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke. Neurology, 1992, 42(5): 976-982 被引量：1
5Brott TG, Haley EC Jr, Levy DE, et al. Urgent therapy for stroke.Part Ⅱ. Pilot study of tissue plasminogen activator administered within 90 minutes. Stroke, 1992, 23(5): 632- 640 被引量：1
6Trouillas P, Nighoghossian N, Getenet JC, et al. Open trial of intravenous tissue plasminogen activator in acute carotid territory stroke,Correlations of outcome with clinical and radiological data. Stroke.1996, 27(5): 882-890 被引量：1
7Boysen G, Vorstrup S, Bogousslavsky J. Thrombolysis for stroketine for a consensus. Cerebrovasc Dis, 1996, 6(6): 376-380 被引量：1
8The National Institute of Neurological Disorders and Stroke (NINDS) rt - PA Stroke Study Group. A systems approach to immediate evaluation and management of hyperacute stroke. Experience at eight centers and implications for community practice and patient care. Stroke,1997, 28(8): 1530-1540 被引量：1
9del Zopper GJ, Higashida RT, Furlah AJ, et al. PROACT: a phase Ⅱ randomized trial of recombinant Pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators.Prolyse in Acute Cerebral Thromboembolism. Stroke, 1998, 29(1 ):4-11. 被引量：1
10Tomsick T, Brott T, Barsan W, et al. Prognostic value of the hyperdense middle cerebral artery sign and stroke scale score before ultra early thrombolytic therapy. AJNR Am J Neuroradiol, 1996, 17(1):79-85. 被引量：1
